IDRI and Zydus Sign Agreement for Development of IDRI’s Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar)

July 25th, 2013|Press Releases|

Seattle, WA | July 25, 2013 Seattle, WA, and Ahmedabad, India, July 25, 2013: – In a unique partnership, Zydus, India’s fourth largest healthcare group and an innovation-led global healthcare provider, and IDRI, a Seattle-based non-profit research and product [...]

IDRI CEO Stewart Parker Will Serve on LSIN Panel

July 11th, 2013|Events|

IDRI CEO Stewart Parker Will Serve on LSIN Panel Seattle, WA | June 13, 2013 At this year’s Life Science Innovation Northwest, sponsored by WBBA, IDRI CEO Stewart Parker will serve as a panelist in a session titled “Start [...]

Science Expo Day

May 20th, 2013|Events|

Seattle, WA | May 20, 2013 Be a scientist for a day! IDRI is taking part in the 2013 Science EXPO Day, which features more than 150 exhibits from organizations across the region that will demonstrate how STEM (science, [...]

Bike to Work Day 2013

May 17th, 2013|Events|

Seattle, WA | April 14, 2013   Friday, May 17, is "Bike to Work"day and IDRI is pleased to host a Commuter Station between 6-9 a.m. outside our building at 1616 Eastlake Avenue East, where we'll give away IDRI [...]

GiveBIG 2013

May 15th, 2013|Events|

Seattle, WA | April 30, 2013 IDRI is pleased to be a part of The Seattle Foundation's GiveBIG effort, a one-day, online charitable giving event to inspire people to give generously to nonprofit organizations that make our region a healthier [...]

IDRI Moves into New Space at 1616 Eastlake

May 7th, 2013|Press Releases|

Seattle, WA | May 7, 2013 Seattle, WA, May 7, 2013: IDRI (Infectious Disease Research Institute) has officially moved from its long-time residence in Seattle’s First Hill neighborhood to its new home at 1616 Eastlake Avenue East, where it [...]

IDRI and Medicago Report Positive Results for Phase 1 Clinical Trial for an H5N1 Vaccine

April 17th, 2013|Press Releases|

Seattle, WA | April 17, 2013 SEATTLE, WA, and QUEBEC CITY, QC, April 17, 2013 – IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, [...]

IDRI and Medicago to Present Data at the World Vaccine Congress

April 8th, 2013|Press Releases|

Seattle, WA | April 8, 2013 SEATTLE, WA, and QUEBEC CITY, QC, April 9, 2013 – IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, [...]

WIB-Seattle Metro: A Discussion on Entrepreneurship with Stewart Parker, CEO, IDRI

February 20th, 2013|Events|

Seattle, WA | Jan. 2, 2013 IDRI CEO Stewart Parker will lead a discussion on key lessons and strategies for successful entrepreneurship at a joint meeting of the Women in Bio (WIB)-Seattle Metro chapter and Seattle’s Association for Women [...]

IDRI and Orangelife Register Rapid Diagnostic for Leprosy for Use in Brazil

January 24th, 2013|Press Releases|

Seattle, WA | January 24, 2013 IDRI (Infectious Disease Research Institute), in conjunction with OrangeLife, a Brazilian diagnostic company, today announces the registration of a rapid diagnostic test for leprosy, offering new hope for early diagnosis and treatment. The [...]

Load More